U.S. flag

An official website of the United States government

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO DataSets

Items: 14

1.

Gene expression profile of liver tissue in low-dose, repeated diethylnitrosamine (DEN)-treated rat treated with epigallocatechin gallate (EGCG)

(Submitter supplied) Background: Hepatocellular carcinoma (HCC) is increasing in incidence and treatment is often unsuccessful. Thus, prevention in high-risk patients with established cirrhosis has been proposed as an alternative strategy. It has been suggested that the increased inflammation and fibrogenesis observed during cirrhosis predisposes the liver to future malignant transformation to HCC through a “field effect”. more...
Organism:
Rattus norvegicus
Type:
Expression profiling by array
Platform:
GPL6101
6 Samples
Download data: TXT
Series
Accession:
GSE67880
ID:
200067880
2.

An Immune Gene Expression Signature Associated With Development of Human Hepatocellular Carcinoma Identifies Mice That Respond to Chemopreventive Agents

(Submitter supplied) Background & Aims: Cirrhosis and chronic inflammation precede development of hepatocellular carcinoma (HCC) in approximately 80% of cases. We investigated immune-related gene expression patterns in liver tissues surrounding early-stage HCCs and chemopreventive agents that might alter these patterns to prevent liver tumorigenesis. Methods: We analyzed gene expression profiles of non-tumor liver tissues from 392 patients with early-stage HCC (training set, n=167 and validation set, n=225) and liver tissue from patients with cirrhosis without HCC (n=216, controls) to identify changes in expression of genes that regulate the immune response that could contribute to hepatocarcinogenesis. more...
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL21382
22 Samples
Download data: CEL
Series
Accession:
GSE125975
ID:
200125975
3.

DNA methylation-based prognosis and epidrivers in hepatocellular carcinoma

(Submitter supplied) Genome-wide expression analysis of 228 hepatocellular carcinoma and 168 cirrhotic samples as part of a integrated study of gene expression and DNA-methylation de-regulation in patients with hepatocellular carcinoma Analysis of whole-genome transcriptome changes in human samples from hepatocellular carcinoma patients
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL13667
396 Samples
Download data: CEL
Series
Accession:
GSE63898
ID:
200063898
4.

Gene-expression profiles of hepatitis C-related, early-stage liver cirrhosis

(Submitter supplied) BACKGROUND & AIMS: Cirrhosis affects 1% to 2% of the world population and is the major risk factor for hepatocellular carcinoma (HCC). Hepatitis C cirrhosis-related HCC is the most rapidly increasing cause of cancer death in the United States. Noninvasive methods have been developed to identify patients with asymptomatic early-stage cirrhosis, increasing the burden of HCC surveillance, but biomarkers are needed to identify patients with cirrhosis who are most in need of surveillance. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL8432
216 Samples
Download data: TXT
Series
Accession:
GSE15654
ID:
200015654
5.

Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma

(Submitter supplied) Background: It is a challenge to identify those patients who, after undergoing potentially curative treatments for hepatocellular carcinoma, are at greatest risk of recurrence. Such high-risk patients could receive novel interventional measures. An obstacle to the development of genome-based predictors of outcome in patients with hepatocellular carcinoma has been the lack of a means to carry out genomewide expression profiling of fixed, as opposed to frozen, tissues. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL5474
387 Samples
Download data: TXT
Series
Accession:
GSE10143
ID:
200010143
6.

Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma (Validation Set)

(Submitter supplied) Background: It is a challenge to identify those patients who, after undergoing potentially curative treatments for hepatocellular carcinoma, are at greatest risk of recurrence. Such high-risk patients could receive novel interventional measures. An obstacle to the development of genome-based predictors of outcome in patients with hepatocellular carcinoma has been the lack of a means to carry out genomewide expression profiling of fixed, as opposed to frozen, tissues. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL5474
225 Samples
Download data: TXT
Series
Accession:
GSE10142
ID:
200010142
7.

Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma (Training Set, HCC)

(Submitter supplied) Background: It is a challenge to identify those patients who, after undergoing potentially curative treatments for hepatocellular carcinoma, are at greatest risk of recurrence. Such high-risk patients could receive novel interventional measures. An obstacle to the development of genome-based predictors of outcome in patients with hepatocellular carcinoma has been the lack of a means to carry out genomewide expression profiling of fixed, as opposed to frozen, tissues. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL5474
80 Samples
Download data: TXT, XLS
Series
Accession:
GSE10141
ID:
200010141
8.

Gene Expression in Fixed Tissues and Outcome in Hepatocellular Carcinoma (Training Set, Liver)

(Submitter supplied) Background: It is a challenge to identify those patients who, after undergoing potentially curative treatments for hepatocellular carcinoma, are at greatest risk of recurrence. Such high-risk patients could receive novel interventional measures. An obstacle to the development of genome-based predictors of outcome in patients with hepatocellular carcinoma has been the lack of a means to carry out genomewide expression profiling of fixed, as opposed to frozen, tissues. more...
Organism:
Homo sapiens
Type:
Expression profiling by array
Platform:
GPL5474
82 Samples
Download data: TXT
Series
Accession:
GSE10140
ID:
200010140
9.

EGFR inhibition prevents liver cirrhosis and hepatocellular carcinoma

(Submitter supplied) This SuperSeries is composed of the SubSeries listed below.
Organism:
Rattus norvegicus; Mus musculus
Type:
Expression profiling by array
Platforms:
GPL6101 GPL6885
35 Samples
Download data
Series
Accession:
GSE27641
ID:
200027641
10.

Gene expression profile of liver tissue in carbon tetrachloride (CCl4)-treated mouse treated with erlotinib

(Submitter supplied) Gene-expression profiles of liver tissue of cabon tetrachloride (CCl4)-treated mouse and the effect of erlotinib Hepatocellular carcinoma (HCC) is the sixth most common solid tumor worldwide and the third leading cause of cancer-related death. Given the lack of successful treatment options, chemoprevention in high-risk patients has been proposed as an alternative strategy. Mounting evidence supports a role for epidermal growth factor (EGF) during chronic liver disease and hepatocellular transformation. more...
Organism:
Mus musculus
Type:
Expression profiling by array
Platform:
GPL6885
8 Samples
Download data: TXT
Series
Accession:
GSE27640
ID:
200027640
11.

Gene expression profile of hepatocellular carcinoma in low-dose, repeated diethylnitrosamine (DEN)-treated rat treated with erlotinib

(Submitter supplied) Gene-expression profiles of rat hepatocellular carcinoma induced by diethylnitrosamine (DEN) and the effect of erlotinib Hepatocellular carcinoma (HCC) is the sixth most common solid tumor worldwide and the third leading cause of cancer-related death. Given the lack of successful treatment options, chemoprevention in high-risk patients has been proposed as an alternative strategy. Mounting evidence supports a role for epidermal growth factor (EGF) during chronic liver disease and hepatocellular transformation. more...
Organism:
Rattus norvegicus
Type:
Expression profiling by array
Platform:
GPL6101
6 Samples
Download data: TXT
Series
Accession:
GSE27638
ID:
200027638
12.

Gene expression profile of liver tissue in low-dose, repeated diethylnitrosamine (DEN)-treated rat treated with erlotinib

(Submitter supplied) Gene-expression profiles of rat liver cirrhosis induced by diethylnitrosamine and the effect of erlotinib on liver fibrogenesis and liver cancer development Hepatocellular carcinoma (HCC) is the sixth most common solid tumor worldwide and the third leading cause of cancer-related death. Given the lack of successful treatment options, chemoprevention in high-risk patients has been proposed as an alternative strategy. more...
Organism:
Rattus norvegicus
Type:
Expression profiling by array
Platform:
GPL6101
21 Samples
Download data: TXT
Series
Accession:
GSE19057
ID:
200019057
13.

Next Generation Sequencing Facilitates Quantitative Analysis of control, NDEA, NDEA + CFT-1 and NDEA+FYT Transcriptomes

(Submitter supplied) Purpose: Next-generation sequencing (NGS) has revolutionized systems-based analysis of cellular pathways. The goals of this study are to compare transcriptome profiling (RNA-seq) between treatment and control model samples. Results: Using the RNA-seq analysis workflow, we mapped about an average of 80 million sequence reads per sample to the rat genome (Rnor_6.0) and identified 34,194 transcripts. more...
Organism:
Rattus norvegicus
Type:
Expression profiling by high throughput sequencing
Platform:
GPL24688
12 Samples
Download data: TXT
Series
Accession:
GSE126796
ID:
200126796
14.

Captopril treatment in rats with DEN-induced cirrhosis and hepatocellular carcinoma

(Submitter supplied) Hepatocellular carcinoma (HCC) is one of the leading cause of cancer-related mortality worldwide. Liver cirrhosis is well-established risk factor of HCC development, although prevention of HCC in cirrhosis patients is challenging. By utilizing bioinformatic compound screening based on a clinical HCC-risk-predicitve gene signature, we identified captopril as a potential HCC chemoprevention agent. We tested the drug in rats with diethylnitrosamine (DEN)-induced cirrhosis and HCC, and confirmed its HCC-preventive effect.
Organism:
Rattus norvegicus
Type:
Expression profiling by high throughput sequencing
Platform:
GPL25029
9 Samples
Download data: GCT
Series
Accession:
GSE157919
ID:
200157919
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

db=gds|term=|query=1|qty=4|blobid=MCID_6629dd37f436486715470d17|ismultiple=true|min_list=5|max_list=20|def_tree=20|def_list=|def_view=|url=/Taxonomy/backend/subset.cgi?|trace_url=/stat?
   Taxonomic Groups  [List]
Tree placeholder
    Top Organisms  [Tree]

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center